Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant
3 years ago
Pharma
Delaware court dismisses Merck's talc liability suit against Bayer
3 years ago
Pharma
J&J spinout loses bid to delay talc bankruptcy case as it heads to Supreme Court
3 years ago
Pharma
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
3 years ago
Pharma
Pharma faces ripple effects from federal court's cutting of preventive care
3 years ago
Whoops: CMS quietly pares back list of drugs requiring new rebates under Inflation Reduction Act
3 years ago
Pharma
US government to SCOTUS: Take up the Teva-GSK 'skinny' generic drug label case
3 years ago
Pharma
Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm
3 years ago
Ohio attorney general sues several PBMs over antitrust concerns
3 years ago
Pharma
House committee chair requests info from FDA on funding for trials involving 'viral manipulation'
3 years ago
FDA+
Esperion sues Daiichi Sankyo, demanding payment of $300M milestone for cardio drug
3 years ago
Pharma
Heated oral arguments at SCOTUS hint at Sanofi-Regeneron edge over Amgen in patent spat
3 years ago
Judge allows expert testimony in GSK trial alleging Zantac link to cancer
3 years ago
Pharma
Senate committee advances PBM bill as bipartisan reforms gain traction
3 years ago
Pharma
Patients appeal NIH's rejection to use 'march-in' rights on Astellas' prostate cancer drug Xtandi
3 years ago
Federal judge denies Amgen's motion to dismiss Regeneron antitrust case
3 years ago
Pharma
NIH rejects another attempt to 'march-in' on Astellas' prostate cancer drug over excessive price
3 years ago
Pharma
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
3 years ago
Pharma
One final push: EU pharma industry group demands competition check on incoming legislative overhaul
3 years ago
Pharma
A sign of what's coming? Presidential hopeful DeSantis targets PBMs and pharma transparency
3 years ago
People
Merck, Viatris agree to settle patent feud surrounding diabetes drugs
3 years ago
Pharma
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
3 years ago
Pharma
Moderna's 'surprise' IP court order could set up a big settlement for Roivant, Arbutus — analysts
3 years ago
CMS explains how it will negotiate the most expensive drug prices with biopharma beginning in 2026
3 years ago
Pharma
First page
Previous page
22
23
24
25
26
27
28
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit